These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 22364720

  • 1. Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.
    Connell PS, Han RI, Grande-Allen KJ.
    J Vet Cardiol; 2012 Mar; 14(1):31-45. PubMed ID: 22364720
    [Abstract] [Full Text] [Related]

  • 2. Pathology of myxomatous mitral valve disease in the dog.
    Fox PR.
    J Vet Cardiol; 2012 Mar; 14(1):103-26. PubMed ID: 22386587
    [Abstract] [Full Text] [Related]

  • 3. Comparative pathology of human and canine myxomatous mitral valve degeneration: 5HT and TGF-β mechanisms.
    Oyama MA, Elliott C, Loughran KA, Kossar AP, Castillero E, Levy RJ, Ferrari G.
    Cardiovasc Pathol; 2020 Mar; 46():107196. PubMed ID: 32006823
    [Abstract] [Full Text] [Related]

  • 4. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans.
    Aupperle H, Disatian S.
    J Vet Cardiol; 2012 Mar; 14(1):59-71. PubMed ID: 22364722
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of innervation of the mitral valves and the effects of myxomatous degeneration in dogs.
    Culshaw GJ, French AT, Han RI, Black A, Pearson GT, Corcoran BM.
    Am J Vet Res; 2010 Feb; 71(2):194-202. PubMed ID: 20113227
    [Abstract] [Full Text] [Related]

  • 6. The mechanobiology of mitral valve function, degeneration, and repair.
    Richards JM, Farrar EJ, Kornreich BG, Moїse NS, Butcher JT.
    J Vet Cardiol; 2012 Mar; 14(1):47-58. PubMed ID: 22366572
    [Abstract] [Full Text] [Related]

  • 7. Cell maceration scanning electron microscopy and computer-derived porosity measurements in assessment of connective tissue microstructure changes in the canine myxomatous mitral valve.
    Han RI, Impoco G, Culshaw G, French AT, Black A, Corcoran BM.
    Vet J; 2013 Aug; 197(2):502-5. PubMed ID: 23465749
    [Abstract] [Full Text] [Related]

  • 8. Interstitial cells from dogs with naturally occurring myxomatous mitral valve disease undergo phenotype transformation.
    Disatian S, Ehrhart EJ, Zimmerman S, Orton EC.
    J Heart Valve Dis; 2008 Jul; 17(4):402-11; discussion 412. PubMed ID: 18751470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Brain-natriuretic peptide and cyclic guanosine monophosphate as biomarkers of myxomatous mitral valve disease in dogs.
    Moesgaard SG, Falk T, Teerlink T, Guðmundsdóttir HH, Sigurðardóttir S, Rasmussen CE, Olsen LH.
    Vet J; 2011 Sep; 189(3):349-52. PubMed ID: 20822939
    [Abstract] [Full Text] [Related]

  • 14. Morphological changes to endothelial and interstitial cells and to the extra-cellular matrix in canine myxomatous mitral valve disease (endocardiosis).
    Han RI, Clark CH, Black A, French A, Culshaw GJ, Kempson SA, Corcoran BM.
    Vet J; 2013 Aug; 197(2):388-94. PubMed ID: 23465752
    [Abstract] [Full Text] [Related]

  • 15. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
    Boswood A, Gordon SG, Häggström J, Vanselow M, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2020 May; 34(3):1108-1118. PubMed ID: 32200574
    [Abstract] [Full Text] [Related]

  • 16. Comparison of cellular changes in Cavalier King Charles spaniel and mixed breed dogs with myxomatous mitral valve disease.
    Lu CC, Liu MM, Culshaw G, French A, Corcoran B.
    J Vet Cardiol; 2016 Jun; 18(2):100-9. PubMed ID: 26860643
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Insights into serotonin signaling mechanisms associated with canine degenerative mitral valve disease.
    Oyama MA, Levy RJ.
    J Vet Intern Med; 2010 Jun; 24(1):27-36. PubMed ID: 19912520
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.